We look at the latest data on the effects of COVID-19 on cancer practices and explore how you can adapt to changes in oncology business.
Find the CANCER BUZZ podcast on Apple Podcasts, Spotify, or wherever you get your podcasts!
Diagnoses of the six most prevalent cancers have decreased sharply, according to recent reports—indicative of big changes to oncology during the pandemic. On this mini-podcast, we look at the latest data on the effects of COVID-19 on cancer practices and explore how you can adapt to changes in oncology business.
Guest: Jennifer Webster, MS, Vice President of Analytics and Data Solutions, Integra Connect
Related Content:
This mini-podcast is supported by educational grants from AstraZeneca Pharmaceuticals, Merck & Co., Inc., and Pfizer Inc.
The views and opinions expressed herein are those of the author(s)/faculty member(s) and do not reflect the official policy or position of their employer(s) or the Association of Cancer Care Centers.
July 8, 2026
June 30, 2026
At the 2026 ASCO Annual Meeting, the Louisiana Oncology Society received the ASCO Jeffrey C Ward Affiliate Advocacy Award for advancing critical advocacy priorities that have translated into meaningful legislative victories. The Iowa Oncology Society and Washington State Medical Oncology Society were also recognized for their advocacy efforts in 2025 at the meeting, receiving second place awards.
